Despite considerable heterogeneity, tumours with one or two truncating mutations in TSC2 showed reduced levels of TSC2 mRNA transcripts compared to non-TSC tissues (pair-wise Welch’s t-tests; FDR-adjusted P=0.01) (Fig. 1m). This evidence concerns the gene TSC2 and tuberous sclerosis.